Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Treasury Shares (2016 - 2025)

Immucell's Treasury Shares history spans 16 years, with the latest figure at $130760.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 5.58% year-over-year to $130760.0; the TTM value through Dec 2025 reached $130760.0, down 5.58%, while the annual FY2025 figure was $130760.0, 5.58% down from the prior year.
  • Treasury Shares reached $59771.0 in Q4 2025 per ICCC's latest filing, roughly flat from $59771.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $283000.0 in Q1 2025 to a low of $59771.0 in Q2 2025.
  • Average Treasury Shares over 5 years is $77450.0, with a median of $67301.0 recorded in 2022.
  • Peak YoY movement for Treasury Shares: decreased 16.02% in 2021, then increased 0.0% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $158171.0 in 2021, then fell by 6.92% to $147233.0 in 2022, then fell by 5.94% to $138482.0 in 2023, then changed by 0.0% to $138482.0 in 2024, then dropped by 5.58% to $130760.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Treasury Shares are $130760.0 (Q4 2025), $130760.0 (Q3 2025), and $130760.0 (Q2 2025).